Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess

By Moran C.   Reyna R.   Boots L.S.   Azziz R.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 126-131

Elsevier

Access to resources Recommend Favorite

Leptin receptor variant in women with polycystic ovary syndrome

By Erel C.T.   Cine N.   Elter K.   Kaleli S.   Senturk L.M.   Baysal B.  

Fertility and Sterility, Vol. 78, Iss. 6, 2002-12 ,pp. : 1334-1335

Elsevier

Access to resources Recommend Favorite

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome

By Azziz R.   Ehrmann D.A.   Legro R.S.   Fereshetian A.G.   O'Keefe M.   Ghazzi M.N.   PCOS/Troglitazone Study Group  

Fertility and Sterility, Vol. 79, Iss. 4, 2003-04 ,pp. : 932-937

Elsevier

Access to resources Recommend Favorite

Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome

By Wu X.-K.   Sallinen K.   Zhou S.-Y.   Su Y.-H.   Pollanen P.   Erkkola R.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 730-734

Elsevier

Access to resources Recommend Favorite

Role of the follistatin gene in women with polycystic ovary syndrome

By Calvo R.M.   Villuendas G.   Sancho J.   San Millan J.L.   Escobar-Morreale H.F.  

Fertility and Sterility, Vol. 75, Iss. 5, 2001-05 ,pp. : 1020-1023

Elsevier

Access to resources Recommend Favorite